环球印务(002799) - 2023 Q1 - 季度财报(更正)

Financial Performance - The company's revenue for Q1 2023 was ¥404,959,881.53, a decrease of 24.95% compared to ¥539,587,507.41 in the same period last year[4] - Net profit attributable to shareholders was ¥28,729,049.41, representing an increase of 4.84% from ¥27,402,907.36 year-on-year[4] - The company's net profit for Q1 2023 was not explicitly stated, but the significant decrease in revenue and costs indicates a challenging financial environment[22] - The net profit for Q1 2023 was CNY 32,498,774.16, an increase of 1.79% compared to CNY 31,925,678.59 in Q1 2022[24] - The operating profit for the quarter was CNY 36,058,491.19, slightly up from CNY 35,695,830.95 in the same period last year[24] - The total profit amounted to CNY 35,958,491.19, compared to CNY 35,695,830.96 in Q1 2022, reflecting a growth of 0.74%[24] Cash Flow and Liquidity - The net cash flow from operating activities was -¥10,698,900.14, a decline of 141.46% compared to ¥25,807,505.26 in the previous year[4] - Cash flow from operating activities showed a net outflow of CNY -10,698,900.14, a significant decrease from a net inflow of CNY 25,807,505.26 in Q1 2022[27] - Cash flow from investing activities resulted in a net outflow of CNY -73,779,314.12, compared to CNY -7,366,367.50 in the same quarter last year[28] - Cash flow from financing activities recorded a net outflow of CNY -119,900,261.61, worsening from CNY -61,006,303.84 in Q1 2022[28] - Cash and cash equivalents at the end of the reporting period amount to RMB 711,217,748.73, down from RMB 906,522,100.48 at the beginning of the year[19] - The total cash and cash equivalents at the end of the quarter were CNY 682,889,219.70, down from CNY 233,565,112.62 at the end of Q1 2022[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,483,533,511.47, down 4.46% from ¥2,599,603,496.21 at the end of the previous year[4] - Accounts receivable increased to CNY 541,890,087.14 from CNY 446,449,714.46, reflecting a rise of approximately 21%[21] - Total liabilities decreased to CNY 771,114,976.93 from CNY 919,683,735.82, a reduction of about 16%[21] - Inventory decreased by 47.77% to ¥49,875,558.27, attributed to increased sales and reduced stocking[9] Shareholder Information - Total number of common shareholders at the end of the reporting period is 20,804[12] - The largest shareholder, Shaanxi Pharmaceutical Holdings Group Co., Ltd., holds 36.42% of shares, totaling 116,550,000 shares[12] Investments and Projects - Cash paid for fixed asset purchases surged by 742.03% to ¥65,552,148.76, reflecting significant investments in key production equipment[10] - The company is constructing a green packaging smart manufacturing industrial park, which includes primary and secondary pharmaceutical packaging production centers and a technology R&D center[16] - The registered capital for the new materials project company in Tianjin is not less than RMB 80 million, with a total investment of at least RMB 100 million[17] Tax and Expenses - The company’s tax expenses increased by 64.99% to ¥3,118,220.95 due to higher VAT payments[10] - Research and development expenses for Q1 2023 were CNY 14,132,285.59, down from CNY 16,502,638.89, a decrease of approximately 13%[22] Future Outlook - The company plans to focus on market expansion and new product development to enhance future growth prospects[22]